Select Publications

Preprints

Mileshkin LR; Moore KN; Barnes EH; Gebski V; Narayan K; King MT; Bradshaw N; Lee YC; Diamante K; Fyles AW; Small W; Gaffney DK; Khaw P; Brooks S; Thompson JS; Huh WK; Mathews CA; Buck M; Suder A; Lad TE; Barani IJ; Holschneider CH; Van Dyk S; Quinn M; Rischin D; Monk BJ; Stockler MR, Adjuvant Chemotherapy Following Chemo-Radiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemo-Radiation Alone: The Randomised Phase 3 OUTBACK Trial (ANZGOG 0902, RTOG 1174, NRG 0274), http://dx.doi.org/10.2139/ssrn.4335106

Werner B; Powell E; Duggan J; Cortesi M; Lee YC; Arora V; Athavale R; Dean M; Warton K; Ford CE, Cell-free DNA from ascites identifies clinically relevant variants and tumour evolution in patients with advanced ovarian cancer, http://dx.doi.org/10.1101/2024.03.09.24303840

Evans HE; Firriolo A-M; Houweling RE; Kelada L; Stannard G; Frawley J; McGill B; Ramus SJ; Lee YC; Friedlander M; Duggan J; Wakefield C, Evaluating Patient Perspectives about the Acceptability of a Novel Prognostic Gene Expression Signature for High Grade Serous Ovarian Cancer The OTTA-SPOT study, http://dx.doi.org/10.2139/ssrn.5605974


Back to profile page